The following medicines will have their prices realigned downwards only from 1 July 2017 as per the attached spreadsheets. These price reductions are being carried out in accordance with the provisions of Clause 5.2 of the 2016 Framework Agreement on the Supply and Pricing of Medicines between IPHA, the Department of Health, the Department of Public Expenditure & Reform and the HSE.
